Received Dec 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | U006486 | OT |
no medical concerns or symptoms based on this report; a dose of MMR II with a labeled expiration date of 2/26/2023 was administered to a patient after expiration on 3/7/2023; This Spontaneous report was received from a nurse and referred to a patient of unknown age and gender. The patient's medical history, past medications, concurrent conditions, and concomitant medications were not reported. On 07-Mar-2023, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine (M-M-R II), Powder and solvent for solution for injection, 0.5 mL, total (valid lot number: U006486, expiration date reported and confirmed as 26-Feb-2023; two dose series; route of administration and anatomical location were not reported) as prophylaxis (expired product administered). The suspect vaccine was reconstituted with sterile diluent (Hollister-Stier STERILE DILUENT) (lot number and expiry date not provided). The reporter confirmed that no medical concerns or symptoms were reported.
Sterile diluent